Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns Drugs like Ozempic, Wegovy, Zepbound and Mounjaro have been around for years, but theyve recently been making headlines due to a rise in popularity as weight loss agents
These medications can cause hypoglycemia independently, and the additive effect of higher GLP-1 levels could tip the balance
This is not glamorous medicine, but it is important medicine
GLP-1 receptor agonists enhance insulin secretion, suppress glucagon, slow gastric emptying, and promote satiety through central pathways
You also get measured, not estimated: the monthly BIA test shows fat versus muscle in a way no scale or online check-in form can, and when you have a question or a side effect, you call a local clinic and reach people who already know your chart